These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17643402)

  • 1. Tight control of adrenal medulla catecholamine release by alpha 2C-adrenergic receptors influences susceptibility to heart failure.
    Petrashevskaya N; Liggett SB
    Cardiovasc Res; 2007 Sep; 75(4):631-3. PubMed ID: 17643402
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction.
    Gilsbach R; Brede M; Beetz N; Moura E; Muthig V; Gerstner C; Barreto F; Neubauer S; Vieira-Coelho MA; Hein L
    Cardiovasc Res; 2007 Sep; 75(4):728-37. PubMed ID: 17597596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha2-adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice.
    Moura E; Afonso J; Hein L; Vieira-Coelho MA
    Br J Pharmacol; 2006 Dec; 149(8):1049-58. PubMed ID: 17075569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α₂-Adrenoceptor-mediated inhibition of catecholamine release from the adrenal medulla of spontaneously hypertensive rats is preserved in the early stages of hypertension.
    Moura E; Pinto CE; Caló A; Serrão MP; Afonso J; Vieira-Coelho MA
    Basic Clin Pharmacol Toxicol; 2011 Oct; 109(4):253-60. PubMed ID: 21518261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes.
    Brede M; Nagy G; Philipp M; Sorensen JB; Lohse MJ; Hein L
    Mol Endocrinol; 2003 Aug; 17(8):1640-6. PubMed ID: 12764077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenoceptor polymorphisms and heart failure.
    Lohse MJ
    Trends Mol Med; 2004 Feb; 10(2):55-8. PubMed ID: 15106619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha- and beta-receptor control of catecholamine secretion from isolated adrenal medulla cells.
    Greenberg A; Zinder O
    Cell Tissue Res; 1982; 226(3):655-65. PubMed ID: 6291765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha 2C Del322-325 adrenergic receptor polymorphism is not associated with heart failure due to idiopathic dilated cardiomyopathy in black Africans.
    Du Preez J; Matolweni LO; Greenberg J; Mntla P; Adeyemo AA; Mayosi BM
    Cardiovasc J Afr; 2008; 19(1):15-6. PubMed ID: 18320080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis.
    Schneider J; Lother A; Hein L; Gilsbach R
    Basic Res Cardiol; 2011 Jun; 106(4):591-602. PubMed ID: 21547520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha2-adrenoceptors in adrenomedullary chromaffin cells: functional role and pathophysiological implications.
    Artalejo AR; Olivos-Oré LA
    Pflugers Arch; 2018 Jan; 470(1):61-66. PubMed ID: 28836008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo interactions between prejunctional alpha 2- and beta 2-adrenoceptors at the level of the adrenal medulla.
    Foucart S; de Champlain J; Nadeau R
    Can J Physiol Pharmacol; 1988 Oct; 66(10):1340-3. PubMed ID: 2907300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heart failure on catecholamine granule morphology and storage in chromaffin cells.
    Mahata SK; Zheng H; Mahata S; Liu X; Patel KP
    J Endocrinol; 2016 Sep; 230(3):309-23. PubMed ID: 27402067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of adrenergic receptors and the risk of heart failure.
    Meisel C; Köpke K; Roots I
    N Engl J Med; 2003 Jan; 348(5):468-70; author reply 468-70. PubMed ID: 12556550
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential release of epinephrine by glycine from adrenal chromaffin cells.
    Yadid G; Youdim MB; Zinder O
    Eur J Pharmacol; 1992 Oct; 221(2-3):389-91. PubMed ID: 1426016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of prolonged glucagon infusions on the urinary excretion of catecholamines and 4-hydroxy-3-methoxymandelic acid and on adrenal medullary tissue levels of catecholamines in patients with severe cardiac disease.
    Hinterberger H; Wilcken DE
    Clin Chim Acta; 1974 Apr; 52(2):153-61. PubMed ID: 4828228
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitric oxide modulates evoked catecholamine release from canine adrenal medulla.
    Barnes RD; Ward LE; Frank KP; Tyce GM; Hunter LW; Rorie DK
    Neuroscience; 2001; 104(4):1165-73. PubMed ID: 11457599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PACAP stimulates catecholamine release from adrenal medulla: a novel noncholinergic secretagogue.
    Watanabe T; Shimamoto N; Takahashi A; Fujino M
    Am J Physiol; 1995 Nov; 269(5 Pt 1):E903-9. PubMed ID: 7491942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of adrenergic receptors and the risk of heart failure.
    Maitland ML; Gomberg-Maitland M
    N Engl J Med; 2003 Jan; 348(5):468-70; author reply 468-70. PubMed ID: 12557866
    [No Abstract]   [Full Text] [Related]  

  • 20. Adrenergic-receptor polymorphisms and heart failure.
    Hajjar RJ; MacRae CA
    N Engl J Med; 2002 Oct; 347(15):1196-9. PubMed ID: 12374881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.